Response to: 'Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1' by Michot et al and 'Checkpoint inhibitor-associated immune arthritis' by Arnaud et al

Affiliations

Comment

Marie Kostine et al. Ann Rheum Dis. 2019 Jul.

. 2019 Jul;78(7):e69.

doi: 10.1136/annrheumdis-2018-213691. Epub 2018 Jun 22.

¹ Department of Rheumatology, Centre Hospitalier Universitaire, Bordeaux, France.

No abstract available

Keywords: T cells; autoimmune diseases; multidisciplinary team-care; systemic lupus erythematosus; treatment.

Conflict of interest statement

Competing interests: None declared.

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM. Kostine M, et al. Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16. Ann Rheum Dis. 2018. PMID: 29146737
Checkpoint inhibitor-associated immune arthritis.
Arnaud L, Lebrun-Vignes B, Salem JE. Arnaud L, et al. Ann Rheum Dis. 2019 Jul;78(7):e68. doi: 10.1136/annrheumdis-2018-213470. Epub 2018 May 3. Ann Rheum Dis. 2019. PMID: 29724725 No abstract available.
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.
Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O. Michot JM, et al. Ann Rheum Dis. 2019 Jul;78(7):e67. doi: 10.1136/annrheumdis-2018-213677. Epub 2018 Jun 1. Ann Rheum Dis. 2019. PMID: 29858173 No abstract available.